Pimicotinib Earns Approval in China for Tenosynovial Giant Cell Tumors
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma: SRN-101, an immuno-gene therapy, has been granted fast track designation for recurring high-grade glioma.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma: KTX-1001, a novel small molecule, shows promising early activity in treating relapsed or refractory multiple myeloma based on a phase 1 trial.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC: 2025 data on the usage of proton therapy for oropharyngeal cancer suggests potential benefits such as immune preservation and reduced long-term AEs.
3 Things You Should Know About PSMA-Directed Imaging and Radioligand Therapy in Prostate Cancer: PSMA PET could offer improved staging and guide radioligand therapy sequencing in prostate cancer, while addressing real-world access issues.
Characterizing TILs in Pancreatic NET Liver Metastases: Research is being done on assessing TCR-based therapies in pancreatic NETs, based on the capability of selected TILs to provide anti-tumor effect.
